FIBROGEN

Serial Number 90328258
Registration 6455210
700

Registration Progress

Application Filed
Nov 18, 2020
Under Examination
Approved for Publication
Jun 1, 2021
Published for Opposition
Jun 1, 2021
Registered
Aug 17, 2021

Trademark Image

FIBROGEN

Basic Information

Serial Number
90328258
Registration Number
6455210
Filing Date
November 18, 2020
Registration Date
August 17, 2021
Published for Opposition
June 1, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 17, 2021
Registration
Registered
Classes
001 005

Rights Holder

FibroGen, Inc.

03
Address
350 Bay Street, Suite 100 #6009
San Francisco, CA 94133

Ownership History

FibroGen, Inc.

Original Applicant
03
San Francisco, CA

FibroGen, Inc.

Owner at Publication
03
San Francisco, CA

FibroGen, Inc.

Original Registrant
03
San Francisco, CA

Legal Representation

Attorney
Harold Milstein

USPTO Deadlines

Next Deadline
646 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-08-17)
Due Date
August 17, 2027
Grace Period Ends
February 17, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

21 events
Date Code Type Description Documents
Oct 7, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 7, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 7, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 7, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Oct 7, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 15, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 15, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 15, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 17, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 1, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 1, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 12, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 30, 2021 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Loading...
Apr 29, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 29, 2021 IUAA P USE AMENDMENT ACCEPTED Loading...
Apr 29, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 28, 2021 IUAF S USE AMENDMENT FILED Loading...
Jan 28, 2021 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jan 27, 2021 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Jan 22, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 21, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Connective Tissue Growth Factor (CTGF) and anti-connective tissue growth factor antibodies for research and diagnostic use; prolyl hydroxylase inhibitors for research use
First Use Anywhere: Jan 7, 2021
First Use in Commerce: Jan 7, 2021
Class 005
Connective Tissue Growth Factor (CTGF) and anti-connective tissue growth factor antibodies for clinical and pharmaceutical use; prolyl hydroxylase inhibitors for clinical or pharmaceutical use
First Use Anywhere: Jan 7, 2021
First Use in Commerce: Jan 7, 2021

Classification

International Classes
001 005